Taltz (ixekizumab)

pCPA File Number: 21192

Negotiation Status:

Concluded without agreement

Indication(s):

Ankylosing spondylitis

Sponsor/Manufacturer:

Eli Lilly Canada Inc.

CADTH Project Number:

SR0630-000

pCPA Engagement Letter Issued:

2021-01-13

Negotiation Process Concluded:

2021-03-19